The Sylvester Comprehensive Cancer Center at the University of Miami announces openings for the Cancer Epigenetics Training Program, funded by the National Cancer Institute's T32 Training Grant Award to being August 2020.
T32 Cancer Epigenetics Program is federally funded by the NIH and postdoc scholars receive a stipend as well as health care benefits from the program.
The objective of the training program is to offer postdoctoral fellows a sophisticated, scientific environment with multidisciplinary expertise encompassing epigenetics and cancer. The program provides trainees with the ideal platform for successful careers as scientists, physicians, scientific administrators, and entrepreneurs who will identify novel agents and devices to treat cancer.
• Must be a US Citizen or Permanent Resident or a non-citizen national, or must have been lawfully admitted for permanent residence and possess an Alien Registration Receipt Card (1-151 or 1-551) or some other verification of legal admission as a permanent resident.
• Must have 1st author publications from Ph.D. thesis or prior Post-Doctoral work.
• Must be within 4 years of obtaining their Ph.D.
• M.D.s must be within 4 years of their residency or fellowship
• Candidates must be available for a full-time, 12-month appointment and agree to undertake a minimum of two years of research, research training, or comparable experiences from the time of appointment.
For application instructions, click here